“In addition to simplified programming and ongoing management of InterStim therapy, the smart programmer is discreet, which is meaningful to patients because OAB can greatly impact confidence, ...

San Francisco, CA USA (UroToday.com) -- Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence. Medtronic plc announced U.S. Food and Drug ...

MINNEAPOLIS--(BUSINESS WIRE)--July 5, 2006--Medtronic, Inc. (NYSE:MDT - News), today announced that the U.S. Food and Drug Administration (FDA) has approved the company's InterStim® II system for the ...

Medtronic continues to up its game in sacral neuromodulation. FDA approved InterStim X, the next generation of the company's InterStim portfolio's recharge-free device. Medtronic said implants have ...